source
- Johnson & Johnson to spend up to $750 million restructuring pharma manufacturing and closing plantsJohnson & Johnson announced it will incur up to $750 million as it reshapes its pharmaceutical manufacturing network. The plan involves exiting certain factories and consolidating production, aimi…
- AdvanCell secures $315M Series D to advance lead-based prostate cancer therapyAdvanCell announced a $315 million Series D financing round aimed at supporting development of its lead-based prostate cancer agent and expanding U.S. manufacturing capacity for the radioactive tre…